價(jià)格 | 詢價(jià) | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2025-08-01 |
中文名稱:奧樂(lè)妥珠單抗 | 英文名稱:Otlertuzumab |
CAS:1372645-37-8 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對(duì)照抗體 | |
抗體名: Otlertuzumab | 靶點(diǎn): CD37, Tspan-26, TSPAN26, Leukocyte antigen CD37, Tetraspanin-26 |
宿主: Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對(duì)照抗體: Otlertuzumab |
Tags:Otlertuzumab 代理商,Otlertuzumab 價(jià)格,Otlertuzumab 供應(yīng)商, Otlertuzumab supplier,Otlertuzumab purchase,Otlertuzumab 購(gòu)買,Otlertuzumab 銷售
Catalog No.
DHC85103
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
VH-V-kappa-CH2-CH3
Applications
Research Grade Biosimilar
Target
CD37, Tspan-26, TSPAN26, Leukocyte antigen CD37, Tetraspanin-26
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P11049
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
TRU-016, CAS: 1372645-37-8
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (5年) | 注冊(cè)資本 | 500萬(wàn) |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1000萬(wàn)-5000萬(wàn) |
主營(yíng)行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 試劑 |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥30000 |
VIP5年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2025-07-21 | |
¥4100 |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2025-07-31 | |
詢價(jià) |
VIP4年
|
江西瑞威爾生物科技有限公司
|
2025-07-09 |